Field Notes on a Quiet Workhorse: 250ml Medical Plastic Vaccine Vial Blue Translucent

In vaccine operations, the bottle almost never gets the headline—until it fails. This one doesn’t. Over the last year I’ve seen it on fill-finish pilots and in cold-chain trials, and, to be honest, it’s been…boringly reliable. Which is exactly what you want.

Why it’s trending

Big batch diluents, bulk intermediates, and combo antigen programs are pushing beyond classic 10 mL formats. The 250ml Medical Plastic Vaccine Vial Blue Translucent hits a sweet spot: light, tough, and engineered for aseptic lines. Many customers say the weight savings alone helps in distribution kits.

Quick specs (real-world values)

How it’s made (and tested)

Material pellets are dried, injected into a preform, then blow-formed—single pass—so the wall stays consistently ≈1.3–1.6 mm. After trimming and visual inspection, lots undergo: burst/creep tests (up to ≈200 kPa), autoclave cycles, particulates per USP <788>, and extractables screening aligned with USP <661.1>/<1663>. Sterilization validation typically follows ISO 11135 (EtO) or gamma dose mapping if required.

Use cases

• Bulk vaccine diluent and buffer pools on small fill–finish lines
• Clinic replenishment packs in outreach campaigns (cold-chain kits)
• Veterinary vaccines and adjuvant blends (field use)
• Biotech pilot lots, media, and intermediates where glass is overkill

Feedback has been positive; one buyer said, “surprisingly sturdy in transport,” which sounds faint—but it’s high praise in this niche.

Vendor snapshot (what buyers compare)

Customization and options

Color tone, cap/liner chemistry, surface printing (lot, date, QR), and pre-sterilized gamma/EtO variants are available. I guess the smart move is aligning liner material with your adjuvant system to keep extractables ultra-low.

Mini case studies

Public health pilot, SE Asia: Switched to the 250ml Medical Plastic Vaccine Vial Blue Translucent for buffer concentrate. Breakage dropped to zero; pack-out weight −14% across 10,000 kits. No sterility failures recorded in 3 months.

Veterinary lot, LATAM: Adopted this model for oil-in-water adjuvant blends. After 121°C validation runs, viscosity shift was negligible; caps maintained torque retention after 1,200 km road transit (ASTM D4169 profile, in-house).

What to verify before you buy

• COA plus resin lot traceability and biocompatibility summary (ISO 10993 screening)
• Extractables/leachables risk per USP <661.1>/<1663> for your specific formulation
• Distribution testing (e.g., ASTM D4169) with your secondary packaging
• QMS certification (ISO 13485) and sterilization validation dossier

Authoritative citations:

1. ISO 13485:2016 – Medical devices QMS. https://www.iso.org/standard/59752.html
2. USP <661.1> Plastic Materials of Construction. https://www.usp.org
3. ISO 10993 (series) – Biological evaluation of medical devices. https://www.iso.org/standard/86862.html
4. WHO – Guidelines on the international packaging and shipping of vaccines. https://www.who.int/publications